Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 7,489-7,500 of 12,112
Other study type icon
CompletedNCT01244490

Extended-release Guanfacine Hydrochloride for ADHD

This study is completed in the United States, in France, in Canada, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.

Multiple locations, including San Diego
ADHDOtherFrom 6 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Shire
Condition
ADHD
Other study type icon
CompletedNCT00741598

Galantamine for Bipolarity

This study is completed in the United States. It is testing galantamine for Bipolarity.

Multiple locations, including Boston
BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Bipolarity
Other study type icon
CompletedNCT00254202

Iloperidone Compared With Placebo and Active Control for schizophrenia

This study is completed in the United States and in India. It is testing iloperidone Compared With Placebo and Active Control for schizophrenia.

Multiple locations, including Little Rock
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States, India
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
Other study type icon
CompletedNCT00735371

Lisdexamfetamine Dimesylate (LDX) for ADHD

This study is completed in the United States. It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.

Multiple locations, including Little Rock
ADHDOtherFrom 13 Years to 17 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
Other study type icon
TerminatedNCT00771134

Lu AA39959 for depression in bipolarity

This study was terminated in the United States. It is testing Lu AA39959 for depression in bipolarity.

In Atlanta
Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01239030

Methylphenidate HCl ER Capsules for ADHD

This study is completed in the United States. It is testing Methylphenidate HCl ER Capsules for ADHD.

Multiple locations, including Little Rock
ADHDOtherFrom 6 Years to 18 Years
Countries
United States
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
Biological study icon
CompletedNCT02777931

NFC-1 for ADHD

This study is completed in the United States. It is testing NFC-1 for ADHD.

In Baltimore
ADHDOtherFrom 12 Years to 17 Years
Countries
United States
Sponsor
Aevi Genomic Medicine, LLC, a Cerecor company
Condition
ADHD
Other study type icon
CompletedNCT04531982

Pimavanserin for schizophrenia

This study is completed in Argentina, in Bulgaria, in Croatia, .... It is testing pimavanserin for schizophrenia.

Multiple locations, including Buenos Aires
SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Argentina, Bulgaria, Croatia, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT01467713

Ramelteon Sublingual for Bipolarity

This study was terminated in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for Bipolarity.

Multiple locations, including Birmingham
BipolarityOtherFrom 18 Years to 75 Years
Countries
United States, Argentina, Chile, ...
Sponsor
Takeda
Condition
Bipolarity
Other study type icon
TerminatedNCT01467700

Ramelteon Sublingual for depression

This study was terminated in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for depression.

Multiple locations, including Birmingham
Depression, BipolarityOtherFrom 18 Years to 75 Years
Countries
United States, Argentina, Chile, ...
Sponsor
Takeda
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT03325881

SHP465 at 6.25 mg for ADHD

This study is completed in the United States. 25 mg for ADHD.

Multiple locations, including Dothan
ADHDOtherFrom 6 Years to 12 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.